University of Arizona

Amount: $100,000

Award date: 2026

Duration: 18 months

Program area: Bioscience

Translational Seed Grant: Endometrial cancer is the most prevalent gynecologic malignancy in the United States and Arizona, with incidence and mortality rates continuing to rise. Current diagnostic procedures, such as dilation and curettage or endometrial biopsy, are invasive, costly, and often inaccessible. The team is developing a non-invasive diagnostic platform leveraging cervicovaginal sampling and biomarker analysis for detection. Their custom multiplex biomarker assay optimized for clinical implementation aims to reduce diagnostic delays and improve outcomes for women.